216 related articles for article (PubMed ID: 22231866)
41. Allelic heterogeneity of GNE gene mutation in two Tunisian families with autosomal recessive inclusion body myopathy.
Amouri R; Driss A; Murayama K; Kefi M; Nishino I; Hentati F
Neuromuscul Disord; 2005 May; 15(5):361-3. PubMed ID: 15833430
[TBL] [Abstract][Full Text] [Related]
42. Selective pattern of muscle involvement seen in distal muscular dystrophy associated with anoctamin 5 mutations: a follow-up muscle MRI study.
Mahjneh I; Bashir R; Kiuru-Enari S; Linssen W; Lamminen A; Visser Md
Neuromuscul Disord; 2012 Oct; 22 Suppl 2():S130-6. PubMed ID: 22980764
[TBL] [Abstract][Full Text] [Related]
43. Identification of an
Garland J; Stephen J; Class B; Gruber A; Ciccone C; Poliak A; Hayes CP; Singhal V; Slota C; Perreault J; Gavrilova R; Shrader JA; Chittiboina P; Joe G; Heiss J; Gahl WA; Huizing M; Carrillo N; Malicdan MCV
Mol Genet Genomic Med; 2017 Jul; 5(4):410-417. PubMed ID: 28717665
[TBL] [Abstract][Full Text] [Related]
44. Hereditary inclusion body myopathy: single patient response to GNE gene Lipoplex therapy.
Nemunaitis G; Maples PB; Jay C; Gahl WA; Huizing M; Poling J; Tong AW; Phadke AP; Pappen BO; Bedell C; Templeton NS; Kuhn J; Senzer N; Nemunaitis J
J Gene Med; 2010 May; 12(5):403-12. PubMed ID: 20440751
[TBL] [Abstract][Full Text] [Related]
45. Autosomal-dominant distal myopathy with a myotilin S55F mutation: sorting out the phenotype.
Berciano J; Gallardo E; Domínguez-Perles R; Gallardo E; García A; García-Barredo R; Combarros O; Infante J; Illa I
J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):205-8. PubMed ID: 17698502
[TBL] [Abstract][Full Text] [Related]
46. Distal myopathy with rimmed vacuoles is allelic to hereditary inclusion body myopathy.
Nishino I; Noguchi S; Murayama K; Driss A; Sugie K; Oya Y; Nagata T; Chida K; Takahashi T; Takusa Y; Ohi T; Nishimiya J; Sunohara N; Ciafaloni E; Kawai M; Aoki M; Nonaka I
Neurology; 2002 Dec; 59(11):1689-93. PubMed ID: 12473753
[TBL] [Abstract][Full Text] [Related]
47. Mutation in GNE Downregulates Peroxiredoxin IV Altering ER Redox Homeostasis.
Chanana P; Padhy G; Bhargava K; Arya R
Neuromolecular Med; 2017 Dec; 19(4):525-540. PubMed ID: 28895049
[TBL] [Abstract][Full Text] [Related]
48. Discordant manifestations in Italian brothers with GNE myopathy.
Dotti MT; Malandrini A; Lornage X; Mignarri A; Cantisani TA; Bohm J; Laporte J; Malfatti E
J Neurol Sci; 2018 Mar; 386():1-3. PubMed ID: 29406958
[No Abstract] [Full Text] [Related]
49. Biochemical characterization of the M712T-mutation of the UDP-N-acetylglucosamine 2-epimerase/N-acetyl-mannosaminekinase in hereditary inclusion body myopathy.
Weidemann W; Reinhardt A; Thate A; Horstkorte R
Neuromuscul Disord; 2011 Dec; 21(12):824-31. PubMed ID: 21873062
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of muscle activity just after straight leg raising exercise by using
Shiozawa H; Ohsawa T; Tsushima Y; Higuchi T; Takagishi K; Chikuda H
J Orthop Sci; 2018 Mar; 23(2):328-333. PubMed ID: 29287785
[TBL] [Abstract][Full Text] [Related]
51. Gene analysis and clinical features of 22 GNE myopathy patients.
Guo X; Zhao Z; Shen H; Bing Q; Li N; Chen J; Hu J
Neurol Sci; 2022 Aug; 43(8):5049-5056. PubMed ID: 35438352
[TBL] [Abstract][Full Text] [Related]
52. Muscle MRI in Ullrich congenital muscular dystrophy and Bethlem myopathy.
Mercuri E; Lampe A; Allsop J; Knight R; Pane M; Kinali M; Bonnemann C; Flanigan K; Lapini I; Bushby K; Pepe G; Muntoni F
Neuromuscul Disord; 2005 Apr; 15(4):303-10. PubMed ID: 15792870
[TBL] [Abstract][Full Text] [Related]
53. Expanding the clinicopathological-genetic spectrum of GNE myopathy by a Chinese neuromuscular centre.
Zhang KY; Duan HQ; Li QX; Luo YB; Bi FF; Huang K; Yang H
J Cell Mol Med; 2021 Nov; 25(22):10494-10503. PubMed ID: 34676965
[TBL] [Abstract][Full Text] [Related]
54. A case of GNE myopathy mimicking hereditary motor neuropathy.
Huang YN; Chuang HJ; Hsueh HW; Huang HC; Lee NC; Chao CC; Huang PH; Lee YC; Lin KP; Yang CC; Hsieh ST
Eur J Neurol; 2020 Nov; 27(11):2389-2391. PubMed ID: 32860282
[TBL] [Abstract][Full Text] [Related]
55. Clinical utility of RNA sequencing to resolve unusual GNE myopathy with a novel promoter deletion.
Chakravorty S; Berger K; Arafat D; Nallamilli BRR; Subramanian HP; Joseph S; Anderson ME; Campbell KP; Glass J; Gibson G; Hegde M
Muscle Nerve; 2019 Jul; 60(1):98-103. PubMed ID: 30990900
[TBL] [Abstract][Full Text] [Related]
56. Novel GNE mutations in two phenotypically distinct HIBM2 patients.
Weihl CC; Miller SE; Zaidman CM; Pestronk A; Baloh RH; Al-Lozi M
Neuromuscul Disord; 2011 Feb; 21(2):102-5. PubMed ID: 21131200
[TBL] [Abstract][Full Text] [Related]
57. Ganglioside GM3 levels are altered in a mouse model of HIBM: GM3 as a cellular marker of the disease.
Paccalet T; Coulombe Z; Tremblay JP
PLoS One; 2010 Apr; 5(4):e10055. PubMed ID: 20383336
[TBL] [Abstract][Full Text] [Related]
58. Pre Clinical Assessment of AAVrh74.MCK.GNE Viral Vector Therapeutic Potential: Robust Activity Despite Lack of Consistent Animal Model for GNE Myopathy.
Mitrani-Rosenbaum S; Yakovlev L; Becker Cohen M; Argov Z; Fellig Y; Harazi A
J Neuromuscul Dis; 2022; 9(1):179-192. PubMed ID: 34806613
[TBL] [Abstract][Full Text] [Related]
59. GNE Myopathy as a Myofibrillar Myopathy: Potential Important Disease Mechanism Implied by Muscle Biopsy.
Chrisman C; McKeever PE
J Clin Neuromuscul Dis; 2020 Dec; 22(2):90-96. PubMed ID: 33214394
[TBL] [Abstract][Full Text] [Related]
60. Computed tomography and magnetic resonance imaging of affected muscle in childhood acid alpha-glucosidase deficiency: a case report.
Arai Y; Osawa M; Shishikura K; Suzuki H; Saito K; Fukuyama Y; Sugie H
Brain Dev; 1993; 15(2):147-52. PubMed ID: 8214335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
